Cryoport, Inc. (CYRX) vs Donaldson Company, Inc. (DCI)
The same free fields, in the same order, for both companies, so a figure on one line can be read straight across.
This page states measurements and nothing else. It does not rank the two companies, name one of them, or draw a conclusion from the figures.
Data as of Oct 27, 2026, for both companies.
The figures, field by field
A dash means the snapshot carries no figure for that company on that line. A line is dropped only when neither company has it, so a dash beside a figure is a fact about coverage, not about either company.
| CYRX | DCI | |
|---|---|---|
| Sector | Industrials | Industrials |
| Industry | Integrated Freight & Logistics | Specialty Industrial Machinery |
| Size band | SMALL | MID |
| Listing | Nasdaq CM | NYSE |
| Country | United States | United States |
| Theme | cell-therapy | industrial-machinery |
| Price and returns | ||
| Last close | $17.79 | $85.51 |
| Return · 1 week | +4.77% | −2.07% |
| Return · 1 month | +2.36% | −2.25% |
| Return · 3 months | +17.27% | −10.33% |
| Return · year to date | +86.09% | −4.66% |
| Return · 1 year | +71.06% | +2.93% |
| Distance from the 52-week highThe last close measured against the highest close of the past 52 weeks. | −5.02% | −24.22% |
| 52-week high | $18.73 | $112.84 |
| 52-week low | $7.61 | $79.61 |
| Size and turnover | ||
| Market value · USDConverted to US dollars, so two companies listed in different currencies sit under one heading. | $901.05M | $9.90B |
| Turnover · median day, USDThe median value traded in a session over the past 50 sessions. | $10.14M | $49.28M |
| Employees | 684 | 15,500 |
| Valuation | ||
| Price to earnings · trailing | n/a (negative earnings) | 23.64× |
| Price to earnings · forward | n/a (negative forward earnings) | 18.75× |
| Price to sales | 4.88× | 2.72× |
| Price to book | 2.05× | 5.98× |
| Enterprise value to EBITDA | n/a (negative EBITDA) | 16.29× |
| Enterprise value to revenue | 4.25× | 2.99× |
| PEG ratio | n/a (negative earnings) | 1.65 |
| Earnings per share · trailing | -0.81 | 3.85 |
| Profitability | ||
| Gross margin | 47.08% | 34.64% |
| Operating margin | −20.45% | 17.09% |
| Profit margin | −21.94% | 11.68% |
| Return on equity | −6.54% | 28.21% |
| Return on assets | −2.39% | 10.92% |
| Growth | ||
| Revenue growth | +7.70% | +8.00% |
| Earnings growth | — | +14.00% |
| Balance sheet and payout | ||
| Debt / equity (%) | 47.28 | 75.09 |
| Current ratio | 2.08 | 2.08 |
| Dividend yield | 0.00% | 1.36% |
| Payout ratio | 0.00% | 31.69% |
| Trend and volatility | ||
| RSI · 14 | 56.15 | 40.19 |
| ADX · 14 | 17.21 | 17.81 |
| 50-day average | $16.77 | $88.90 |
| 200-day average | $13.15 | $90.89 |
| Average true range · share of priceAverage true range over 14 sessions, stated as a share of the last close, so it can be read across two share prices. | 4.06% | 1.95% |
The full CYRX analysis
Everything this table leaves out for Cryoport, Inc.: the plain-language summary and key points, the accumulation read, signal history, full fundamentals, market context, and the case each side of the CYRX argument makes.
$9.90 per stock, one time, 30 days of access.
Open the full CYRX analysisThe full DCI analysis
Everything this table leaves out for Donaldson Company, Inc.: the plain-language summary and key points, the accumulation read, signal history, full fundamentals, market context, and the case each side of the DCI argument makes.
$9.90 per stock, one time, 30 days of access.
Open the full DCI analysis